North America Therapeutic Dog Food Market

The North America therapeutic dog food market is expected to grow from US$ 2,196.93 million in 2021 to US$ 3,196.70 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028.

 Due to their significant impact on human life since their domestication, dogs are viewed as the most appropriate companion animal in humans. They promote an active lifestyle, provide emotional companionship, and have superior detection capabilities for several purposes. Pets help bring social, emotional, and cognitive development in children, in addition to helping adults in relieving stress and anxiety. Research studies have shown that dog owners are at a 36% lower risk of dying from cardiovascular disease and an 11% lower risk of a heart attack. As per the American Pet Products Association's 2019–2020 survey, ~63.4 Million households own at least one dog in the US. Thus, the surging preference for dogs as a companion is fueling the therapeutic dog food market growth.

As per the Insurance Research Council’s October 2020 report, during the COVID-19 pandemic, around 30% of Americans adopted a pet for companionship. Most of the consumers in the market grappled with the onset of the pandemic. The retail e-commerce platforms witnessed high growth due to several restrictions on the brick-and-mortar stores and the disruption in the overall supply channel.​ The pandemic has accelerated an online shift as social distancing changes habits. Changes in pet ownership are another long-term consequence of the COVID-19 outbreak. A few online retailers also reported strong sales. For instance, Chewy.com has witnessed an acceleration in sales since February 2020. Chewy.com generates around 70% of its sales through subscribed customers. All these developments suggest increased online penetration due to the pandemic. Also, the pet population of dogs has increased in the region because of lockdown and people wanting a companion. Home isolation have driven the short-term pet fostering programs that may translate into long-term pet population growth in the future. However, misinformation related to the infection of novel coronavirus to animals has driven pet abandonments in North America. Despite many disruptions caused by COVID-19 containment measures, the long-term growth potential of the healthcare sector remains intact.

With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America therapeutic dog food market. The therapeutic dog food market is improving with initiatives led by animal welfare associations, dog food manufacturers, and governments. Governments are raising awareness concerning health conditions and animal diseases, and also facilitating the privatization of animal healthcare services. The PetFAST Reporting System tracks any suspected pet illness associated with pet food sold in the country. Such systems urge the manufacturers to maintain optimum product quality and hence assist in augmenting the brand identity of the products and thus facilitate the market growth. A surge in pet ownership and growing consumer awareness has spurred demand for pet products, and companies are launching various campaigns to increase consumer awareness. For instance, in June 2021, MARS Petcare introduced a new advertising campaign promoting Pedigree’s Small Dog pet food rang. The new advertising campaign promotes the concept of feeding the right food to small dogs.

  North America Therapeutic Dog Food Market Revenue and Forecast to 2028 (US$ Million)

North America Therapeutic Dog Food Market Segmentation

• North America Therapeutic Dog Food Market – By Product Type

  • Dry Food
  • Wet/ Canned Food
  • Snacks/ Treats
  • Others

• North America Therapeutic Dog Food Market – By Application

  • Weight Management
  • Digestive Care
  • Allergy and Immune System Health
  • Others

• North America Therapeutic Dog Food Market – By Country

  • US
  • Canada
  • Mexico

North America Therapeutic Dog Food Strategic Insights

Strategic insights for the North America Therapeutic Dog Food provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Therapeutic Dog Food Report Scope

North America Therapeutic Dog Food Regional Insights

The geographic scope of the North America Therapeutic Dog Food refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.